SBRT Versus Surgery in the COVID-19 Era: What Has Changed and What Hasn't?
Suresh Senan, MRCP, FRCR, PhDSurgery is considered the preferred treatment in patients with lung cancer who are fit to undergo the procedure. Stereotactic radiotherapy (SBRT) is guideline recommended for patients who are unfit for […] Read more
Increasing Understanding about the Role Biosimilar Agents in Everyday Practice: A Q&A with Dr. Gary Lyman (Part 1 of 2)
Gary Lyman, MD, MPHIn September 2017, the FDA approved bevacizumab-awwb for the treatment of NSCLC, with the same indications as the tradename agent. Although bevacizumab-awwb is the only biosimilar agent specific to lung […] Read more
December 18, 2020—The U.S. Food and Drug Administration (FDA) approved osimertinib as post-resection adjuvant therapy for patients with NSCLC and EGFR exon 19 deletions or exon 21 L858R mutations, as […] Read more
Leora Horn, MD, MSc, FRCPC, has joined AstraZeneca as the Global Head of Lung Cancer Strategy. Prior to joining AstraZeneca in September 2020, Dr. Horn was an Associate Professor of […] Read more
Associate Professor of Nursing at Yale University, Marianne J. Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP, added Fellow of the American Academy of Nursing (FAAN) to her impressive list […] Read more
Interstitial Lung Abnormality, Interstitial Lung Disease, and Lung Cancer
Hiroto Hatabu, MD, PhD, FACR+more
As a practicing chest radiologist in Boston, one of this article’s authors (Dr. Hatabu) encounters several patients with drug-related pneumonitis (DRP) daily when on clinical duty. Sometimes DRP coexists with […] Read more
Alexander Drilon, MD
Alexander Drilon, MD, is now Memorial Sloan Kettering Cancer Center’s Chief of the Early Drug Development (EDD) Service in the Division of Solid Tumor Oncology of the Department of Medicine. […] Read more
Pembrolizumab Is Active in Lung Cancer Brain Metastases
Sarah B. Goldberg, MDIn Reference To: Goldberg SB, Schalper KA, Gettinger SN, et al. Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, […] Read more
The Role of Nurse Navigators in Lung Cancer: Advocates, Sounding Boards, and Care Coordinators for Patients
Megan Roy, BSN, RN, OCNMy primary goal as a nurse navigator is to provide patient-centered care while facilitating timely access to the right providers. Nurse navigators have the clinical expertise to individualize both their […] Read more
Using Tumor Radiomic Features To Predict NSCLC Chemotherapy Response
Michelle Hershman, MD+more
IN REFERENCE TO: Khorrami M, Jain P, Bera K, et al. Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features. Lung Cancer. 2019;135:1-9. Read more